Save & Grow Money   

@howtobuybest

Buzzing #Stock: Astec Lifesciences shares jump 6% after September quarter profit surges 238%

31/10/2020 01:09:25 PM     Share:    

---

  SanthanamVaidya   

@sanvai

#AstecLifesciences 1161, +6% Q2 sterling show. Stock to break out of month range!

30/10/2020 12:59:04 PM     Share:    

---

  Stock Infinities 🇮🇳   

@StockInfinities

Astec LifeSciences profit increases 10.25% in (Q2) FY 2020-21

29/10/2020 07:01:16 PM     Share:    

---

  Shreenidhi P   

@nid_rockz

Good nos-28th oct post 4 till 7 Astec lifesciences Bajaj healthcare-pbt up 5x,pat up 6.5x,H1 eps of 26 Surya roshni-pbt,pat n ocf 2x Orient cement- turnaround,q2 eps of 1.7rs, huge ocf-6x Blue dart-turnaround SIS-q2 eps of 7.3,pbt up 2.2x,ocf at 342cr vs -15cr Mrpl

29/10/2020 06:57:04 PM     Share:    

---

  #STOCK ANALYSE   

@alkeshthakkar

#asteclife ASTEC LIFESCIENCES RESULT

29/10/2020 06:18:31 PM     Share:    

---

  EquityBulls.com   

@equitybulls

Astec LifeSciences Ltd's consolidated PAT rises to Rs. 17.84 crore in Q2FY21 #AstecLifeSciences #Q2FY21 #H1FY21 #ResultUpdate

29/10/2020 05:18:04 PM     Share:    

---

  Shreenidhi P   

@nid_rockz

Astec lifesciences Good quarter Slightly better than q1 runrate which is good Pbt at 24cr vs 7.8cr Pat at 18cr vs 5.2cr Eps of 17.5rs for h1 Decent ocf yoy

29/10/2020 04:46:04 PM     Share:    

---

  PIYUSH JAIN   

@stockgurupiyush

Top expected Results today Maruti BPCL Indigo Havells Vodafone Idea TVS Motor BoB Shriram Transport Laurus Labs Canara Bank Tata Chemicals Blue Dart Welspun India Strides Pharma Zensar Tech Welspun Corp Astec Lifesciences JK Paper Orient Cement #stocks #nifty

29/10/2020 08:08:30 AM     Share:    

---

  SanthanamVaidya   

@sanvai

#LaurusLabs 320, -5%. 52wHigh 343 #VinatiOrganics 1230, -2%. 1419 #NeulandLab1198, flat. 1201 #AstecLifesciences 1082, -3%. 1367 #SuvenPharma 334, -2%. 416 ... API CRAM Contract mfg Intermediate ....story? Is the crack an invitation to buy/add? Or Call to Exit?

26/10/2020 01:05:34 PM     Share:    

---

  Shreenidhi P   

@nid_rockz

Very good report of equirus on astec lifesciences The finer details on the company and industry in this report is a must read

22/09/2020 11:45:35 AM     Share:    

---

  ETMarkets   

@ETMarkets

Buy Astec Lifesciences, target price Rs 1838: Equirus Securities #ETMarkets #DailyRecos #StockPicks #DailyPicks

17/09/2020 12:42:28 PM     Share:    

---

  ASHISH SHAH   

@Ashish_shah72

quirus Securities Pvt Ltd initiated coverage of Astec Lifesciences Ltd. with a recommendation of buy. PT set to 1,838 rupees, implies a 48% increase from last price

16/09/2020 08:47:22 AM     Share:    

---

  Darshan Mehta   

@darshanvmehta1

Equirus Securities Pvt Ltd initiated coverage of Astec Lifesciences Ltd. with a recommendation of buy. PT set to 1,838 rupees, implies a 48% increase from last price

16/09/2020 08:25:38 AM     Share:    

---

  Shreenidhi P   

@nid_rockz

Equirus on astec lifesciences Leader in triazole fungicides Newer mixtures n geographies to aid growth n enhance margins CRAMS in herbicide segment-newer venture and good opportunity size

15/09/2020 09:26:50 PM     Share:    

---

  Motilal Oswal Financial Services Ltd   

@MotilalOswalLtd

Astec LifeSciences sold its entire equity stake of 50.10% in Astec Europe Sprl to Charles Delautre-Drouillon and accordingly, Astec Europe Sprl ceases to be a subsidiary of the company. #MOMarketUpdates

02/09/2020 08:52:12 AM     Share:    

---

  IIFLMarkets   

@IIFLMarkets

Astec LifeSciences sells whole stake in subsidiary Astec Europe Sprl

01/09/2020 10:06:03 AM     Share:    

---

  IIFLMarkets   

@IIFLMarkets

Astec LifeSciences climbs 6% on strong performance despite Covid-19 challenges

21/08/2020 10:16:13 AM     Share:    

---

  Markets Today   

@marketstodays

More than 150 stocks hit their fresh 52-week high on the BSE. These included Atul, Astec Lifesciences, Tata Communications and JB Chemicals.

20/08/2020 05:29:41 PM     Share:    

---

  Motilal Oswal Financial Services Ltd   

@MotilalOswalLtd

Astec LifeSciences reported strong Q1 results. Company reported Revenue up 45.3% to Rs 111.9 crore, Net profit of Rs 16.2 crore from net loss of Rs 1.1 crore, Ebitda up 4.3 times to Rs 28.2 crore and Ebitda margin at 25.2% from 8.4%. #MOMarketUpdates

24/07/2020 08:52:02 AM     Share:    

---

  OnlyStockTips   

@OnlyStockTips

Astec LifeSciences Limited- Result Declared for First Quarter: Unaudited result for Non-Cumulative

23/07/2020 12:32:38 PM     Share:    

---